Pompe Disease: Clinical Trials

1 trial for Pompe Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1
Phase 21Active not recruiting 1

Follow Pompe Disease: new trials by email Literature Review of Pompe Disease trials Research Report on Pompe Disease

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)
SPK-3006 - Pompe Disease, Pompe Disease (Late-onset)
Phase 1 / Phase 2Active not recruitingSpark Therapeutics, Inc.42020-10-012024-11-27

Narrower conditions

Glycogen Storage Disease Type II (1)  ·  Lysosomal Storage Diseases (1)

Broader conditions

Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Carbohydrate Metabolism, Inborn Errors (1)  ·  Central Nervous System Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Glycogen Storage Disease (1)  ·  Lysosomal Storage Diseases, Nervous System (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Nervous System Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Sponsors

Spark Therapeutics, Inc. (1)

Countries

Canada (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Tahseen Mozaffar, MD (1)

NIH funding

2019 (1)